Roles of polyphenols, flavonoids, and oligomeric proanthocyanidins in cancer chemoprevention

Phytopharmaceuticals in Cancer Chemoprevention

Volumn , Issue , 2004, Pages 311-348

  Ray, Sidhartha D ^a   Bagchi, Debasis ^b  

^a LONG ISLAND UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84962341728     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (130)

1. Surh, Y.J., Cancer chemoprevention with dietary phytochemicals, Nat. Rev. Cancer, 3, 768, 2003.
2. Bagchi, D. et al., Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention, Toxicology, 148, 187, 2000.
3. Bagchi, D. et al., Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice, Gen. Pharmacol., 30, 771, 1998.
4. Bagchi, D. et al., Comparative in vitro and in vivo free radical scavenging abilities of a novel grape seed proanthocyanidin extract and selected antioxidants, in Natural Antioxidants and Anticarcinogens in Nutrition, Health and Disease, Kumpulainen, J.T. and Salonen, J.T., Eds., Royal Society of Chemistry, Cambridge, U.K., 1999, pp. 178.
5. Bagchi, D. et al., Hydrogen peroxide-induced modulation of intracellular oxidized states in cultured macrophage J774A.1 and neuroactive PC-12 cells, and protection by a novel grape seed proanthocyanidin extract, Phytotherapy Res., 12, 568, 1998.
6. Bagchi, M. et al., Smokeless tobacco, oxidative stress, apoptosis and antioxidants in human oral keratinocytes, Free Radical Biol. Med., 26, 992, 1999.
7. Ray, S.D., Kumar, M.A., and Bagchi, D., A novel proanthocyanidin IH636 grape seed extract increases in vivo Bcl-XL expression and prevents acetaminophen-induced programmed and unprogrammed cell death in mouse liver, Arch. Biochem. Biophys., 369, 42, 1999.
8. Ray, S.D. et al., In vivo protection of DNA damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicininduced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract, Res. Comm. Mol. Pathol. Pharmacol., 107, 137, 2000.
9. Bagchi, D. et al., Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract, Drugs Exptl. Clin. Res., 27, 3, 2001.
10. Ray, S.D. et al., Unique organo-protective properties of a novel IH636 grape seed proanthocyanidin extract on cadmium chloride-induced nephrotoxicity, dimethylnitrosamine (DMN)-induced spleenotoxicity and MOCAP-induced neurotoxicity in mice, Res. Comm. Mol. Pathol. Pharmacol., 107, 105, 2000.
11. Sato, M. et al., Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury, J. Mol. Cell. Cardiol., 31, 1289, 1999.
12. Bagchi, D. et al., Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract, Mutation Res., 523/524, 87, 2003.
13. Vinson, J.A. et al., Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model, Mol. Cell. Biochem., 240, 99, 2002.
14. Bagchi, M. et al., Acute and chronic stress-induced oxidative gastrointestinal injury in rats, and the protective ability of a novel grape seed proanthocyanidin extract, Nutrition Res., 19, 1189, 1999.
15. Bagchi, M. et al., Protective effects of antioxidants against smokeless tobacco-induced oxidative stress and modulation of Bcl-2 and p53 genes in human oral keratinocytes, Free Radical Res., 35, 181, 2001.
16. Joshi, S.S. et al., Amelioration of the cytotoxic effects of chemotherapeutic agents by grape seed proanthocyanidin extract, Antiox. Redox. Signal., 1, 563, 1999.
17. Joshi, S.S. et al., Chemopreventive effects of grape seed proanthocyanidin extract on Chang liver cells, Toxicology, 155, 83, 2000.
18. Joshi, S.S., Kuszynski, C.A., and Bagchi, D., The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract, Curr. Pharm. Biotech., 2, 187, 2001.
19. Ye, X. et al., The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells, Mol. Cell. Biochem., 196, 99, 1999.
20. Krohn, R.L. et al., Differential effect of a novel grape seed proanthocyanidin extract on cultured human normal and malignant cells, in Natural Antioxidants and Anticarcinogens in Nutrition, Health and Disease, Kumpulainen, J.T. and Salonen, J.T., Eds., Royal Society of Chemistry, Cambridge, U.K., 1999, pp. 443.
21. Bagchi, D. and Preuss, H.G., Oligomeric proanthocyanidins in human health and disease prevention, in Critical Reviews in Oxidative Stress and Aging: Advances in Basic Science, Diagnostics and Intervention, Cutler, R.G. and Rodriguez, H., Eds., World Scientific Publishing, NJ, 2002, pp. 640.
22. Gressier, B. et al., Pro-oxidant properties of methotrexate: evaluation and prevention by an anti-oxidant drug, Pharmazie, 49, 679, 1994.
23. Mayne, S.T., Graham, S., and Zheng, T.Z., Dietary retinol: prevention or promotion of carcinogenesis in humans?, Cancer Causes Control, 2, 443, 1991.
24. Packer, L., Rimbach, G., and Virgili, F., Antioxidant activity and biologic properties of a procyanidinrich extract from pine (Pinus maritima) bark, pycnogenol, Free Radical Biol. Med., 27, 704, 1999.
25. Mittal, A., Elmets, C.A., and Katiyar, S.K., Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation, Carcinogenesis, 24, 1379, 2003.
26. Craig, W.J., Health-promoting properties of common herbs, Amer. J. Clin. Nutr., 70 (3 Suppl.), 491S, 1999.
27. Wiseman, S., Mulder, T., and Rietveld, A., Tea flavonoids: bioavailability in vivo and effects on cell signaling pathway in vitro, Antioxid. Redox Signal., 3, 1009, 2001.
28. Turner, N.J., Thomson, B.M., and Shaw, I.C., Bioactive isoflavones in functional foods: the importance of gut microflora on bioavailability, Nutr. Rev., 61 (6, Pt. 1), 204, 2003.
29. Chao, P.D. et al., Flavonoids in herbs: biological fates and potential interactions with xenobiotics, J. Food Drug Anal., 10, 219, 2002.
30. Hollman, P.C. et al., Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers, Am. J. Clin. Nutr., 62, 1276, 1995.
31. Hollman, P.C., Hertog M.G., and Katan M.B., Role of dietary flavonoids in protection against cancer and coronary heart disease, Biochem. Soc. Trans., 3, 785, 1996.
32. Hollman, P.C. et al., Bioavailability of the dietary antioxidant flavonol quercetin in man, Cancer Lett., 114, 139, 1997.
33. Hollman, P.C., Bioavailability of flavonoids, Eur. J. Clin. Nutr., 51 (Suppl. 1), S66, 1997.
34. Manach, C. et al., Bioavailability of rutin and quercetin in rats, FEBS Lett., 409, 12, 1997.
35. Hollman, P.C. and Katan M.B., Health effects and bioavailability of dietary flavonols, Free Radic. Res., 31, S75, 1999.
36. Walle, T. et al., Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption, J. Nutr., 130, 2658, 2000.
37. Chao, P.D. et al., Quercetin glucuronides inhibited 2-aminofluorene acetylation in human acute mycloid HL-60 leukemia cells, Phytomedicine, 9, 625, 2002.
38. Morand, C. et al., Respective bioavailability of quercetin aglycone and its glycosides in a rat model, Biofactors, 12, 169, 2000.
39. Olthof, M.R. et al., Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans, J. Nutr., 130, 1200, 2000.
40. Ameer, B. et al., Flavanone absorption after naringin, hesperidin, and citrus administration, Clin. Pharmacol. Ther., 60, 34, 1996.
41. Choudhury, R. et al., Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation, Biochem. Biophys. Res. Commun., 265, 410, 1999.
42. Felgines, C. et al., Bioavailability of the flavanone naringenin and its glycosides in rats, Am. J. Physiol. Gastrointest. Liver Physiol., 279, G1148, 2000.
43. Erlund, I. et al., Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice, J. Nutr., 131, 235, 2001.
44. Erlund, I. et al., Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers, Eur. J. Clin. Pharmacol., 56, 545, 2000.
45. Donovan, J.L. et al., Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B3, Br. J. Nutr., 87, 299, 2002.
46. Baba, S. et al., Absorption and urinary excretion of procyanidin B2 [epicatechin-(4beta-8)-epicatechin] in rats, Free Radic. Biol. Med., 33, 142, 2002.
47. Baba, S. et al., Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats, J. Agric. Food Chem., 49, 6050, 2001.
48. Baba, S. et al., In vivo comparison of the bioavailability of (+)-catechin, (+)-epicatechin and their mixture in orally administered rats, J. Nutr., 131, 2885, 2001.
49. Vaidyanathan, J.B. and Walle, T., Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes, Drug Metab. Dispos., 30, 897, 2002.
50. Schramm, D.D. et al., Food effects on the absorption and pharmacokinetics of cocoa flavonols, Life Sci., 73, 857, 2003.
51. Crespy, V. et al., The splanchnic metabolism of flavonoids highly differed according to the nature of the compound, Am. J. Physiol. Gastrointest. Liver Physiol., 284, G980, 2003.
52. Carbonaro, M., Grant, G., and Pusztai, A., Evaluation of polyphenol bioavailability in rat small intestine, Eur. J. Nutr., 40, 84, 2001.
53. Huynh, H.T. and Teel, R.W., Selective induction of apoptosis in human mammary cancer cells (MCF-7) by pycnogenol, Anticancer Res., 20, 2417, 2000.
54. Virgili, F. et al., Ferulic acid excretion as a marker of consumption of a French maritime pine (Pinus maritima) bark extract, Free Radical Biol. Med., 28, 1249, 2000.
55. Piskula, M.K., Factors affecting flavonoids absorption, Biofactors, 12, 175, 2000.
56. Wang, M.Y. and Su, C., Cancer preventive effect of Morinda citrifolia (Noni), Ann. N.Y. Acad. Sci., 952, 161, 2001.
57. Boveris, A., Valdez, L., and Alvarez, S., Inhibition by wine polyphenols of peroxynitrite-initiated chemiluminescence and NADH oxidation, Ann. N.Y. Acad. Sci., 957, 90, 2002.
58. Yamashita, S. et al., Absorption and metabolism of antioxidative polyphenolic compounds in red wine, Ann. N.Y. Acad. Sci., 957, 325, 2002.
59. Lin, Y.T. et al., Degradation of flavonoid aglycones by rabbit, rat and human fecal flora, Biol. Pharm. Bull., 26, 747, 2003.
60. Boue, S.M. et al., Evaluation of the estrogenic effects of legume extracts containing phytoestrogens, J. Agric. Food. Chem., 51, 2193, 2003.
61. Ross, J.A. and Kasum, C.M., Dietary flavonoids: bioavailability, metabolic effects, and safety, Ann. Rev. Nutr., 22, 19, 2002.
62. Rechner, A.R. et al., The metabolism of dietary polyphenols and the relevance to circulating levels of conjugated metabolites, Free Radical Res., 36, 1229, 2002.
63. Rohdewald, P., A review of the French maritime pine bark extract (pycnogenol), a herbal medication with a diverse clinical pharmacology, Int. J. Clin. Pharmacol. Ther., 40, 158, 2002.
64. Koley, A.P., Differential mechanisms of cytochrome P450 inhibition and activation by alphanaphthoflavone, J. Biol. Chem., 272, 3149, 1997.
65. Kenakin, T., Agonist-receptor efficacy, II: agonist trafficking of receptor signals, Trends Pharmacol. Sci., 16, 232, 1995.
66. Bruns, R.F., Conformational induction versus conformational selection: evidence from allosteric enhancers, Trends Pharmacol. Sci., 17, 189, 1996.
67. Obach, R.S., Inhibition of human cytochrome P450 enzymes by constituents of St. John’s wort, an herbal preparation used in the treatment of depression, J. Pharmacol. Exp. Ther., 294, 88, 2000.
68. Ray, S.D. et al., Differential effects of IH636 grape seed proanthocyanidin extract and a DNA repair modulator 4-aminobenzamide on liver microsomal cytochrome P450 2E1-dependent aniline hydroxylation, Mol. Cell. Biochem., 218, 27, 2001.
69. Bailey, D.G. et al., Grapefruit juice--drug interactions, Br. J. Clin. Pharmacol., 46, 101, 1998.
70. Fuhr, U. and Kummert, A.L., The fate of naringin in humans: a key to grapefruit juice-drug interactions?, Clin. Pharmacol. Ther., 58, 365, 1995.
71. Honig, A. et al., Effect of arterial chemoreceptor stimulation with almitrine bismesylate on plasma renin activity, aldosterone, ACTH and cortisol in anaesthetized, artificially ventilated cats, Clin. Exp. Pharmacol. Physiol., 23, 106, 1996.
72. Eaton, E.A. et al., Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase: potential role in drug metabolism and chemoprevention, Drug Metab. Dispos., 24, 232, 1996.
73. Williamson, G., Faulkner K., and Plumb, G.W., Glucosinolates and phenolics as antioxidants from plant foods, Eur. J. Cancer Prev., 7, 17, 1998.
74. de Groot, H. and Rauen, U., Tissue injury by reactive oxygen species and the protective effects of flavonoids, Fundam. Clin. Pharmacol., 12, 249, 1998.
75. Le Marchand, L., Intake of flavonoids and lung cancer, J. Natl. Cancer Inst., 92, 154, 2000.
76. Hammons, G.J., Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes, Nutr. Cancer, 33, 46, 1999.
77. Chinery, R. et al., Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta, Nat. Med., 3, 1233, 1997.
78. Abou-Shoer, M. et al., Flavonoids from Koelreuteria henryi and other sources as protein-tyrosine kinase inhibitors, J. Nat. Prod., 56, 967, 1993.
79. Laughton, M.J, Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives: relationship to antioxidant activity and to iron ion-reducing ability, Biochem. Pharmacol., 42, 1673, 1991.
80. Bracke, M.E. et al., Anti-invasive activity of 3,7-dimethoxyflavone in vitro, J. Pharm. Sci., 83, 1217, 1994.
81. Hirano, T. et al., Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes, Br. J. Cancer, 72, 1380, 1995.
82. So, F.V. et al., Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices, Nutr. Cancer, 26, 167, 1996.
83. Fuhr, U., Drug interactions with grapefruit juice: extent, probable mechanism and clinical relevance, Drug Saf., 18, 251, 1998.
84. Chaumontet, C. et al., Lack of tumor promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication, Nutr. Cancer, 26, 251, 1996.
85. Helin, K., Harlow, E., and Fattaey, A., Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein, Mol. Cell. Biol., 13, 6501, 1993.
86. Weinberg, R.A., The retinoblastoma protein and cell cycle control, Cell, 81, 323, 1995.
87. Mayol, X. and Grana, X., The p130 pocket protein: keeping order at cell cycle exit/re-entrance transitions, Front Biosci., 3, D11, 1998.
88. Dyson, N., The regulation of E2F by pRB-family proteins, Genes Dev., 12, 2245, 1998.
89. Lavia, P. and Jansen-Durr, P., E2F target genes and cell-cycle checkpoint control, Bioessays, 21, 221, 1999.
90. De Azevedo, Jr., W.F. et al., Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase, Proc. Natl. Acad. Sci. USA, 93, 2735, 1996.
91. Losiewicz, M.D. et al., Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275, Biochem. Biophys. Res. Commun., 201, 589, 1994.
92. Carlson, B.A. et al., Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells, Cancer Res., 56, 2973, 1996.
93. Patel, V., Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis, J. Clin. Invest., 102, 1674, 1998.
94. Kerr, J.S. et al., Novel small molecule alpha vs. integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors, Anticancer Res., 19, 959, 1999.
95. Drees, M. et al., Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells, Clin. Cancer Res., 3, 273, 1997.
96. Arguello, F. et al., Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts, Blood, 91, 2482, 1998.
97. Pan, M.H. et al., Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells, Carcinogenesis, 23, 1677, 2002.
98. Pavelic, K. et al., Recent advances in molecular genetics of breast cancer, J. Mol. Med., 79, 566, 2001.
99. Rooprai, H.K., Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro, Neuropathol. Appl. Neurobiol., 27, 29, 2001.
100. Tanaka, T. et al., Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats, Carcinogenesis, 20, 1477, 1999.
101. Joiner, M.C. et al., Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance, Mutat. Res., 358, 171, 1996.
102. Savell, J. et al., Permanent growth arrest in irradiated human fibroblasts, Radiat. Res., 155, 554, 2001.
103. Te Poele, R.H. et al., DNA damage is able to induce senescence in tumor cells in vitro and in vivo, Cancer Res., 62, 1876, 2002.
104. Bagchi, D., Ray, S.D., Bagchi, M., Preuss, H.G., and Stohs, S.J., Mechanistic pathways of antioxidant cytoprotection by a novel IH636 grape seed proanthocyanidin extract, Indian J. Exp. Biol., 40, 717, 2002.
105. Lautraite, S. et al., Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1, Mutagenesis, 17, 45, 2002.
106. Chan, H.Y., Wang, H., and Leung, L.K., The red clover (Trifolium pratense) isoflavone biochanin A modulates the biotransformation pathways of 7,12-dimethylbenz[a]anthracene, Br. J. Nutr., 90, 87, 2003.
107. Park, Y.K. et al., Daily grape juice consumption reduces oxidative DNA damage and plasma free radical levels in healthy Koreans, Mutat. Res., 529, 77, 2003.
108. Quiles, J.L. et al., Antioxidants, nutrients and adriamycin toxicity, Toxicology, 180, 79, 2002.
109. Van Acker, S.A., Intracerebroventricular administration of a glucocorticoid receptor antagonist enhances the cardiovascular responses to brief restraint stress, Eur. J. Pharmacol., 430, 87, 2001.
110. Snyder, R.D. and Gillies, P.J., Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells, Environ. Mol. Mutagen., 40, 266, 2002.
111. Borek, C., Antioxidant health effects of aged garlic extract, J. Nutr., 131, 1010S, 2001.
112. Wei, Y.Q. et al., Induction of apoptosis by quercetin: involvement of heat shock protein, Cancer Res., 54, 4952, 1994.
113. Nagasaka, Y. and Nakamura, K., Modulation of heat-induced activation of mitogen-activated protein (MAP) kinase by quercetin, Biochem. Pharmacol., 56, 1151, 1998.
114. Zarkovic, N. et al., An overview on anticancer activities of the Viscum album extract isorel, Cancer Biother. Radiopharm., 16, 55, 2001.
115. Ray, S.D. et al., IH636 Grape seed proanthocyanidin extract (GSPE) exposure significantly attenuates dimethylnitrosamine (DMN)-induced liver cancer and mortality in B6C3F1 mice, Proc. Am. Assoc. Cancer Res., 41, 460, 2000.
116. Barotto, N.N., Quercetin enhances pretumorous lesions in the NMU model of rat pancreatic carcinogenesis, Cancer Lett., 129, 1, 1998.
117. Sugimura, T., Nutrition and dietary carcinogens, Carcinogenesis, 21, 387, 2000.
118. Tanaka, T., Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination, Carcinogenesis, 18, 761, 1997.
119. Papadimitrakopoulou, V.A. et al., Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions, Cancer Epidemiol. Biomarkers Prev., 11, 1605, 2002.
120. Jankun, J. et al., Why drinking green tea could prevent cancer, Nature, 387, 561, 1997.
121. Sugimura, T., Nutrition and dietary carcinogens, Carcinogenesis, 21, 387, 2000.
122. Katsouyanni, K. et al., Diet and breast cancer: a case-control study in Greece, Int. J. Cancer, 38, 815, 1986.
123. Stefani, E.D. et al., Dietary antioxidants and lung cancer risk: a case-control study in Uruguay, Nutr. Cancer, 34, 100, 1999.
124. Baker, M.E., Flavonoids as hormones: a perspective from an analysis of molecular fossils, Adv. Exp. Med. Biol., 439, 249, 1998.
125. Hsu, I.C. et al., Cell and species differences in metabolic activation of chemical carcinogens, Mutat. Res., 177, 1, 1987.
126. Shaddock, J.G., Snawder, J.E., and Casciano, D.A., Cryopreservation and long-term storage of primary rat hepatocytes: effects on substrate-specific cytochrome P450-dependent activities and unscheduled DNA synthesis, Cell. Biol. Toxicol., 9, 345, 1993.
127. Zou, X.N. et al., Seasonal variation of food consumption and selected nutrient intake in Linxian, a high risk area for esophageal cancer in China, Int. J. Vitam. Nutr. Res., 72, 375, 2002.
128. Poveda, A., Ovarian cancer treatment: what is new, Int. J. Gynecol. Cancer, 13 (Suppl. 2), 241, 2003.
129. Fotsis, T. et al., Genistein, a dietary-derived inhibitor of in vitro angiogenesis, Proc. Natl. Acad. Sci. USA, 90, 2690, 1993.
130. Fotsis, T. et al., Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis, J. Nutr., 125 (3 Suppl.), 790S, 1995.